Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Eliem Therapeutics, Inc. (ELYM)
|
|
| Cash Flow Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Mar-05-23 | Dec-31-22 | Dec-05-22 | Sep-30-22 | Sep-05-22 | Jun-30-22 |
| | 10-Q | 10-Q | 8-K | 10-K | 8-K | 10-Q | 8-K | 10-Q |
| Net income | -5.2 | -22.3 | 0.0 | -7.8 | 0.0 | -9.7 | 0.0 | -14.6 |
| Change in working capital | | | | 7.0 | | | | |
| Other | | | | 7.0 | | | | |
| Other operating activities | -2.7 | 7.1 | | -7.7 | | 5.5 | | 0.6 |
| Cash from operations | -8.0 | -15.2 | | -8.4 | | -4.2 | | -14.0 |
| |
| Capital expenditures | 0.0 | 0.0 | | 0.0 | | 0.0 | | 0.0 |
| Purchases of short-term investments | 38.5 | 17.5 | | 6.7 | | 46.7 | | 8.9 |
| Purchases of short-term investments | 38.5 | 17.5 | | 6.7 | | 46.7 | | 8.9 |
| Other cash from investing | -40.1 | -11.7 | | 7.6 | | -38.2 | | 6.8 |
| Cash from investing | -1.6 | 5.8 | | 14.3 | | 8.5 | | 15.7 |
| |
| Issuance of common stock, net | 0.0 | 0.0 | | | | | | |
| Cash from financing | 0.0 | 0.0 | | 0.0 | | 0.0 | | 0.0 |
| |
| Free cash flow | -8.0 | -15.2 | | -8.4 | | -4.2 | | -14.0 |
| Per share (diluted) | ($0.30) | ($0.57) | | ($0.32) | | ($0.16) | | ($0.53) |
|